Introduction
Malnutrition can take a variety of forms, such as protein-energy malnutrition, and deficiencies of micronutrients, such as iron, iodine, and vitamin A. Among various forms of nutritional deficiencies in children, iron deficiency is the most common form that subsequently results in iron deficiency anemia (IDA). 1 Consequences of IDA are serious and include reduced school performance, decreased growth rate, and impaired motor development. [2] [3] [4] [5] [6] A number of strategies have been suggested to combat this problem including dietary modifications, fortification of food, 7 and iron supplementation orally or parenterally. 8 Among these strategies, daily oral supplementation with medicinal iron for 2-4 months is considered the most effective. Despite its effectiveness, non-compliance is the major problem with this strategy due to gastrointestinal side-effects and difficulty in sustaining motivation to take iron supplements daily for long periods of time. 9, 10 To overcome the problem of non-compliance with daily iron supplementation, researchers have investigated intermittent iron supplementation as an alternative form of therapy. Several animal and human studies have shown equal effectiveness and less gastrointestinal side-effects when intermittent was compared with daily iron supplementation.
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The rationale for intermittent oral iron supplementation is based on the concept of a 'mucosal block' of iron absorption. 15, 16 This theory argues that mucosal enterocytes downregulate iron absorption in response to daily exposure to a high intake of iron. There is an increase in mucosal ferritin synthesis, an increase in the proportion of enterocyte iron that is stored in the cell, and a decrease in transfer of iron to transferrin in the vascular pool. The life span of mucosal cells is 2-3 days and they are sloughed off and replaced by new cells. Therefore, stored iron within the mucosal cells is wasted instead of being absorbed.
The aim of this study was to evaluate the effectiveness of weekly administration of iron supplements compared with daily administration in iron-deficient schoolchildren.
Materials and Methods
The study was conducted in a private school of children of blue-collar workers of in Karachi, Pakistan. Subjects were children aged 5-10 years. All children underwent a thorough history and physical examination. Any children with acute disease such as diarrhea (>4 loose stools per day), fever, cough, running nose, or history of chronic disease (e.g. joint pain or bleeding disorders) were excluded. Children Summary Iron deficiency anemia (IDA) is still a major nutritional and public health problem in developing countries. The prevalence among young children and pregnant women is particularly high. Daily oral supplementation with medicinal iron is considered an effective strategy for reducing the incidence of IDA but non-compliance is a major problem with this strategy. We undertook this study to compare the results of once-weekly vs. daily oral iron supplementation in schoolchildren. Sixty children ranging between 5 and 10 years with iron deficiency anemia were selected from a school in Karachi, Pakistan and were divided into two equal groups, i.e., daily and weekly supplementation groups. Hemoglobin (Hb), hematocrit (Hct), serum iron, total iron binding capacity (TIBC), and serum ferritin were determined before the start of the study. Ferrous sulfate (200 mg) was given daily to the daily supplementation group and once-weekly to the weekly supplementation group for 2 months. When post-supplementation values of the above-mentioned parameters were determined, a significant improvement was observed in all parameters in both groups. It is concluded that once-weekly iron supplementation is as effective as daily supplementation for the treatment of iron deficiency anemia. Moreover, weekly iron supplementation is cost effective and has no or fewer side-effects.
showing clinical anemia with a hemoglobin level below 11 g/dl were included in the study.
Thirty male and 30 female children were selected and were randomly divided into two groups, i.e., daily and weekly supplementation groups. Each group consisted of 15 boys and 15 girls. The daily supplementation group received 200 mg ferrous sulfate daily for 56 days and the weekly supplementation group received the same dose of ferrous sulfate once a week for 2 months (i.e., eight doses). Hemoglobin (Hb), hematocrit (Hct), serum iron, total iron binding capacity (TIBC), and serum ferritin were determined before and after supplementation. Prior to iron supplementation children in both groups were given a single-dose (100 mg) tablet of the anthelmintic agent, mebendazole. Data analysis was performed by using MiniTab statistical software. Values are given as the mean ± SEM. Comparison of the values for indicators of iron status between the two groups was performed using Student's t-test. A p-value of <0.05 was considered significant.
Results
All 60 children completed the study. The age and height of the children in the weekly supplementation group were significantly higher (p < 0.05) than those in the daily supplementation group, while weight and body mass index (BMI) were not significantly different (Table 1 ). There was no significant difference in Hb and Hct, serum iron, TIBC, and serum ferritin levels between the two groups before iron supplementation. Values for all of these parameters were significantly different (p < 0.05) in both the groups after iron supplementation (Tables 2 and 3 ).
Discussion
Nutritional anemia has been a subject of considerable interest for many decades. It is highly prevalent in children, especially in developing countries. Iron, being an integral component of hemoglobin, myoglobin, cytochromes, and the iron-containing enzymes essential for intermediary metabolism, is considered the main culprit in the development of anemia. It is due to higher requirements of iron in children compared with older people, low socioeconomic status, low bioavailability of dietary iron, chronic blood loss, and malabsorptive diseases.
After 8 weeks of supplementation with ferrous sulfate there was a significant rise (p < 0.05) in the concentrations of Hb and Hct in both daily and weekly supplementation groups. These findings lend support to those of Berger, et al. 17 who showed that once-weekly supplementation of iron increases the Hb and Hct to a level similar to that of daily iron supplementation. A number of other studies have also observed a significant rise in these parameters after weekly supplementation. 18, 19 In our study, after supplementation for 8 weeks there was significant increase (p < 0.05) in serum iron concentration in both groups. TIBC is an indicator of the amount of transport iron in the vascular pool. A TIBC value greater than 425 µg/dl may be consistent with iron deficiency (i.e., transferrin not fully saturated with [20] [21] [22] [23] Based on studies on normal volunteers, a concentration of 1 ng/ml of serum ferritin is equivalent to about 8 mg of stored iron. Researchers suggest that ferritin levels provide a more sensitive, specific, and reliable indicator of iron deficiency. 24, 25 Low Hb concentration is the most readily available sign of anemia but a significant fall in circulating hemoglobin cannot be detected until significant iron deficiency has occurred. Serum iron and TIBC do not distinguish iron deficiency as a progressive disease. Also, the measurements are affected by diurnal variation and may not discriminate between depleted iron stores and conditions associated with a defective release of iron from cells in tissues of the reticulo-endothelial system (liver, spleen, and bone marrow), e.g. anemia of chronic disease.
The results of our study demonstrate that onceweekly iron supplementation not only repletes functional iron stores, but storage iron as well, because after weekly supplementation a significant increase (p < 0.05) in serum ferritin concentration was observed.
